{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:15:39Z","timestamp":1792192539456,"version":"4.4.0"},"reference-count":75,"publisher":"American Society of Hematology","issue":"18","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Acute promyelocytic leukemia (APL) is associated with a high risk of bleeding and thrombosis. APL patients have an activated coagulation system, hyperfibrinolysis, and thrombocytopenia. APL cells express tissue factor (TF), a receptor and cofactor for factor VII\/VIIa. This study had 2 goals. Firstly, we measured biomarkers of coagulation and fibrinolysis activation as well as platelet counts and bleeding in both mouse xenograft and allograft models of APL. Secondly, we determined the effect of inhibiting TF on the activation of coagulation in these models. We observed increased levels of plasma thrombin-antithrombin complexes (TAT), D-dimer, and plasmin-antiplasmin complexes, reduced platelet counts, and increased tail bleeding in both mouse models of APL. Fibrinogen levels decreased in the xenograft model but not in the allograft model. In contrast, the red blood cell count decreased in the allograft model but not in the xenograft model. Inhibition of APL-derived human TF with an anti-human TF monoclonal antibody reduced the level of TAT, increased platelet count, and normalized tail bleeding in a xenograft model. Inhibition of all sources of TF (APL cells and host cells) in the allograft model with a rat anti-mouse TF monoclonal antibody decreased the levels of TAT but did not affect the platelet count. Our study demonstrates that TF plays a central role in the activation of coagulation in both the xenograft and allograft mouse models of APL. These APL mouse models can be used to investigate the mechanisms of coagulopathy and thrombocytopenia in APL.<\/jats:p>","DOI":"10.1182\/bloodadvances.2023010466","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T16:48:00Z","timestamp":1689353280000},"page":"5458-5469","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":13,"title":["Tissue factor activates the coagulation cascade in mouse models of acute promyelocytic leukemia"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9157-0524","authenticated-orcid":false,"given":"Yohei","family":"Hisada","sequence":"first","affiliation":[{"name":"1University of North Carolina Blood Research Center, Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6282-4991","authenticated-orcid":false,"given":"Tomohiro","family":"Kawano","sequence":"additional","affiliation":[{"name":"1University of North Carolina Blood Research Center, Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6052-5680","authenticated-orcid":false,"given":"Sierra J.","family":"Archibald","sequence":"additional","affiliation":[{"name":"1University of North Carolina Blood Research Center, Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6656-3672","authenticated-orcid":false,"given":"John S.","family":"Welch","sequence":"additional","affiliation":[{"name":"2Division of Oncology, Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2106-3698","authenticated-orcid":false,"given":"Brandi N.","family":"Reeves","sequence":"additional","affiliation":[{"name":"1University of North Carolina Blood Research Center, Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9170-7700","authenticated-orcid":false,"given":"Nigel","family":"Mackman","sequence":"additional","affiliation":[{"name":"1University of North Carolina Blood Research Center, Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"issue":"3","key":"2023092214050475500_bib1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0092-8674(93)80044-F","article-title":"The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells","volume":"74","author":"Grignani","year":"1993","journal-title":"Cell"},{"issue":"3","key":"2023092214050475500_bib2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3390\/cancers12030624","article-title":"Acute promyelocytic leukemia: a constellation of molecular events around a single PML-RARA fusion gene","volume":"12","author":"Liquori","year":"2020","journal-title":"Cancers"},{"issue":"3","key":"2023092214050475500_bib3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1055\/s-0034-1370792","article-title":"The unique hemostatic dysfunction in acute promyelocytic leukemia","volume":"40","author":"Kwaan","year":"2014","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"2023092214050475500_bib4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2141.1988.tb04204.x","article-title":"Beneficial effect of heparin in the management of patients with APL","volume":"68","author":"Hoyle","year":"1988","journal-title":"Br J Haematol"},{"issue":"3","key":"2023092214050475500_bib5","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1182\/blood.V71.3.690.690","article-title":"Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients","volume":"71","author":"Stone","year":"1988","journal-title":"Blood"},{"issue":"4","key":"2023092214050475500_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-0609.2011.01747.x","article-title":"Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia","volume":"88","author":"Chang","year":"2012","journal-title":"Eur J Haematol"},{"issue":"5","key":"2023092214050475500_bib7","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1182\/blood.V79.5.1305.1305","article-title":"High incidence of disseminated intravascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia","volume":"79","author":"Sarris","year":"1992","journal-title":"Blood"},{"issue":"6","key":"2023092214050475500_bib8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s002770050399","article-title":"Disseminated intravascular coagulation in acute lymphoblastic leukemia at presentation and in early phase of remission induction therapy","volume":"76","author":"Higuchi","year":"1998","journal-title":"Ann Hematol"},{"issue":"8","key":"2023092214050475500_bib9","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1080\/10428190500102662","article-title":"Disseminated intravascular coagulation complicating acute lymphoblastic leukemia: a study of childhood and adult cases","volume":"46","author":"Higuchi","year":"2005","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"2023092214050475500_bib10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/1076029607302435","article-title":"Disseminated intravascular coagulation in acute leukemia at presentation and during induction therapy","volume":"13","author":"Dixit","year":"2007","journal-title":"Clin Appl Thromb Hemost"},{"issue":"2","key":"2023092214050475500_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1532\/IJH97.06173","article-title":"Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation","volume":"86","author":"Uchiumi","year":"2007","journal-title":"Int J Hematol"},{"issue":"14","key":"2023092214050475500_bib12","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1182\/blood-2016-02-701094","article-title":"Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemia","volume":"128","author":"Libourel","year":"2016","journal-title":"Blood"},{"issue":"11","key":"2023092214050475500_bib13","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1182\/blood.V82.11.3241.3241","article-title":"Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group","volume":"82","author":"Fenaux","year":"1993","journal-title":"Blood"},{"issue":"suppl","key":"2023092214050475500_bib14","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1007\/s002800051058","article-title":"All-trans retinoic acid therapy for newly diagnosed acute promyelocytic leukemia: comparison with intensive chemotherapy. The Japan Adult Leukemia Study Group (JALSG)","volume":"40","author":"Asou","year":"1997","journal-title":"Cancer Chemother Pharmacol"},{"issue":"15","key":"2023092214050475500_bib15","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJM199710093371501","article-title":"All-trans-retinoic acid in acute promyelocytic leukemia","volume":"337","author":"Tallman","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"2023092214050475500_bib16","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1182\/blood.V94.4.1192","article-title":"A\u00a0randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group","volume":"94","author":"Fenaux","year":"1999","journal-title":"Blood"},{"issue":"12","key":"2023092214050475500_bib17","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1038\/leu.2009.183","article-title":"High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG","volume":"23","author":"Lengfelder","year":"2009","journal-title":"Leukemia"},{"issue":"5","key":"2023092214050475500_bib18","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1182\/blood-2011-04-346437","article-title":"Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid","volume":"118","author":"Park","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2023092214050475500_bib19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3324\/haematol.2011.046490","article-title":"Treatment advances have not improved the early death rate in acute promyelocytic leukemia","volume":"97","author":"McClellan","year":"2012","journal-title":"Haematologica"},{"issue":"6","key":"2023092214050475500_bib20","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/leu.2017.71","article-title":"Early death rates remain high in high-risk APL: update from the Swedish Acute Leukemia Registry 1997-2013","volume":"31","author":"Lehmann","year":"2017","journal-title":"Leukemia"},{"issue":"51","key":"2023092214050475500_bib21","doi-asserted-by":"crossref","first-page":"e9324","DOI":"10.1097\/MD.0000000000009324","article-title":"Analysis of early death in newly diagnosed acute promyelocytic leukemia patients","volume":"96","author":"Xu","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"2023092214050475500_bib22","doi-asserted-by":"crossref","first-page":"E370","DOI":"10.1002\/ajh.25252","article-title":"Complications and early mortality in patients with acute promyelocytic leukemia treated in California","volume":"93","author":"Ho","year":"2018","journal-title":"Am J Hematol"},{"issue":"13","key":"2023092214050475500_bib23","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1080\/10428194.2019.1613540","article-title":"Acute promyelocytic leukemia (APL): remaining challenges towards a cure for all","volume":"60","author":"Stahl","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"2023092214050475500_bib24","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1182\/blood.V86.3.1072.1072","article-title":"Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid","volume":"86","author":"Falanga","year":"1995","journal-title":"Blood"},{"issue":"4","key":"2023092214050475500_bib25","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1182\/blood.V64.4.791.791","article-title":"Thrombin generation in acute promyelocytic leukemia","volume":"64","author":"Bauer","year":"1984","journal-title":"Blood"},{"issue":"6","key":"2023092214050475500_bib26","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0049-3848(88)90349-0","article-title":"Levels of thrombin-antithrombin III complex in plasma in cases of acute promyelocytic leukemia","volume":"50","author":"Asakura","year":"1988","journal-title":"Thromb Res"},{"issue":"9","key":"2023092214050475500_bib27","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1182\/blood.V91.9.3093","article-title":"The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia","volume":"91","author":"Barbui","year":"1998","journal-title":"Blood"},{"issue":"suppl 1","key":"2023092214050475500_bib28","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1016\/j.thromres.2018.01.038","article-title":"Predictive factors of fatal bleeding in acute promyelocytic leukemia","volume":"164","author":"Mantha","year":"2018","journal-title":"Thromb Res"},{"key":"2023092214050475500_bib29","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.2147\/OTT.S100513","article-title":"Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives","volume":"10","author":"McCulloch","year":"2017","journal-title":"Onco Targets Ther"},{"issue":"3","key":"2023092214050475500_bib30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-0609.2006.00803.x","article-title":"Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome","volume":"78","author":"Yanada","year":"2007","journal-title":"Eur J Haematol"},{"issue":"1","key":"2023092214050475500_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12885-023-10612-z","article-title":"Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021","volume":"23","author":"Gill","year":"2023","journal-title":"BMC Cancer"},{"issue":"4","key":"2023092214050475500_bib32","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/jth.12838","article-title":"Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH","volume":"13","author":"Thachil","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"issue":"10","key":"2023092214050475500_bib33","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1080\/10245332.2018.1470069","article-title":"Characteristics of fibrinolytic disorders in acute promyelocytic leukemia","volume":"23","author":"Wang","year":"2018","journal-title":"Hematology"},{"issue":"6","key":"2023092214050475500_bib34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00277-008-0446-3","article-title":"Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation","volume":"87","author":"Langer","year":"2008","journal-title":"Ann Hematol"},{"key":"2023092214050475500_bib35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40164-015-0018-x","article-title":"Tissue factor-dependent and -independent pathways of systemic coagulation activation in acute myeloid leukemia: a single-center cohort study","volume":"4","author":"Dicke","year":"2015","journal-title":"Exp Hematol Oncol"},{"issue":"13","key":"2023092214050475500_bib36","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJM199904013401303","article-title":"Annexin II and bleeding in acute promyelocytic leukemia","volume":"340","author":"Menell","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"2023092214050475500_bib37","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1182\/blood-2010-07-298851","article-title":"Regulation of S100A10 by the PML-RAR-alpha oncoprotein","volume":"117","author":"O'Connell","year":"2011","journal-title":"Blood"},{"issue":"6","key":"2023092214050475500_bib38","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1160\/TH16-12-0936","article-title":"Mechanism of plasmin generation by S100A10","volume":"117","author":"Miller","year":"2017","journal-title":"Thromb Haemost"},{"issue":"6","key":"2023092214050475500_bib39","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/s41375-018-0069-1","article-title":"Transcriptomic landscape of acute promyelocytic leukemia reveals aberrant surface expression of the platelet aggregation agonist Podoplanin","volume":"32","author":"Lavallee","year":"2018","journal-title":"Leukemia"},{"issue":"6","key":"2023092214050475500_bib40","doi-asserted-by":"crossref","first-page":"873","DOI":"10.7326\/0003-4819-105-6-873","article-title":"Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency","volume":"105","author":"Schwartz","year":"1986","journal-title":"Ann Intern Med"},{"issue":"6","key":"2023092214050475500_bib41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41408-021-00514-3","article-title":"Acute promyelocytic leukemia current treatment algorithms","volume":"11","author":"Yilmaz","year":"2021","journal-title":"Blood Cancer J"},{"issue":"11","key":"2023092214050475500_bib42","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1182\/blood.V75.11.2112.2112","article-title":"Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients","volume":"75","author":"Rodeghiero","year":"1990","journal-title":"Blood"},{"key":"2023092214050475500_bib43","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.2147\/OTT.S144438","article-title":"Low platelet count is potentially the most important contributor to severe bleeding in patients newly diagnosed with acute promyelocytic leukemia","volume":"10","author":"Song","year":"2017","journal-title":"Onco Targets Ther"},{"issue":"2","key":"2023092214050475500_bib44","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.leukres.2010.05.022","article-title":"Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia","volume":"35","author":"Kim","year":"2011","journal-title":"Leuk Res"},{"issue":"13","key":"2023092214050475500_bib45","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1182\/blood-2016-10-747170","article-title":"Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era","volume":"129","author":"Mantha","year":"2017","journal-title":"Blood"},{"issue":"4","key":"2023092214050475500_bib46","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/ATVBAHA.117.309846","article-title":"Tissue factor: an essential mediator of hemostasis and trigger of thrombosis","volume":"38","author":"Grover","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2023092214050475500_bib47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1182\/blood.V92.1.143.413k18_143_151","article-title":"Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells","volume":"92","author":"Falanga","year":"1998","journal-title":"Blood"},{"issue":"8","key":"2023092214050475500_bib48","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3324\/haematol.2011.055343","article-title":"Characterization of the thrombin generation potential of leukemic and solid tumor cells by calibrated automated thrombography","volume":"97","author":"Marchetti","year":"2012","journal-title":"Haematologica"},{"issue":"16","key":"2023092214050475500_bib49","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1007\/s00018-011-0689-3","article-title":"Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles","volume":"68","author":"Gyorgy","year":"2011","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"2023092214050475500_bib50","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.thromres.2013.11.008","article-title":"Microparticle bearing tissue factor: a link between promyelocytic cells and hypercoagulable state","volume":"133","author":"Gheldof","year":"2014","journal-title":"Thromb Res"},{"issue":"3","key":"2023092214050475500_bib51","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.thromres.2013.12.029","article-title":"Clinical evidence for a link between microparticle-associated tissue factor activity and overt disseminated intravascular coagulation in patients with acute myelocytic leukemia","volume":"133","author":"Thaler","year":"2014","journal-title":"Thromb Res"},{"issue":"6","key":"2023092214050475500_bib52","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00277-021-04533-9","article-title":"Tissue factor-bearing microparticles are a link between acute promyelocytic leukemia cells and coagulation activation: a human subject study","volume":"100","author":"Zhao","year":"2021","journal-title":"Ann Hematol"},{"issue":"8","key":"2023092214050475500_bib53","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1182\/blood.V87.8.3404.bloodjournal8783404","article-title":"Establishment of a human acute promyelocytic leukemia-ascites model in SCID mice","volume":"87","author":"Zhang","year":"1996","journal-title":"Blood"},{"issue":"6","key":"2023092214050475500_bib54","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1073\/pnas.94.6.2551","article-title":"A\u00a0PMLRARalpha transgene initiates murine acute promyelocytic leukemia","volume":"94","author":"Brown","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2023092214050475500_bib55","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1182\/blood-2011-04-347187","article-title":"Methionine-induced hyperhomocysteinemia reverts fibrinolytic pathway activation in a murine model of acute promyelocytic leukemia","volume":"120","author":"Jacomo","year":"2012","journal-title":"Blood"},{"key":"2023092214050475500_bib56","doi-asserted-by":"crossref","first-page":"102992","DOI":"10.1016\/j.ebiom.2020.102992","article-title":"Endothelial damage and a thin intercellular fibrin network promote haemorrhage in acute promyelocytic leukaemia","volume":"60","author":"Wang","year":"2020","journal-title":"EBioMedicine"},{"issue":"15","key":"2023092214050475500_bib57","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1182\/bloodadvances.2022006980","article-title":"CD44-fibrinogen binding promotes bleeding in acute promyelocytic leukemia by in situ fibrin(ogen) deposition","volume":"6","author":"Wang","year":"2022","journal-title":"Blood Adv"},{"issue":"11","key":"2023092214050475500_bib58","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1111\/jth.13809","article-title":"Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size","volume":"15","author":"Hisada","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"issue":"8","key":"2023092214050475500_bib59","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1182\/blood-2010-08-300087","article-title":"Rara haploinsufficiency modestly influences the phenotype of acute promyelocytic leukemia in mice","volume":"117","author":"Welch","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2023092214050475500_bib60","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41374-019-0298-6","article-title":"NSG mice as hosts for oncological precision medicine","volume":"100","author":"Maletzki","year":"2020","journal-title":"Lab Invest"},{"key":"2023092214050475500_bib75","unstructured":"The Jackson Laboratory. Accessed 24 July 2023. https:\/\/www.jax.org."},{"issue":"5","key":"2023092214050475500_bib61","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1055\/s-0043-1761419","article-title":"Decreased Platelet Reactivity and Function in a Mouse Model of Human Pancreatic Cancer","volume":"123","author":"Kawano","year":"2023","journal-title":"Thromb Haemost"},{"issue":"23","key":"2023092214050475500_bib62","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1182\/blood-2012-01-402156","article-title":"Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer","volume":"119","author":"Wang","year":"2012","journal-title":"Blood"},{"issue":"7","key":"2023092214050475500_bib63","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1538-7836.2009.03448.x","article-title":"Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice","volume":"7","author":"Wang","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"2023092214050475500_bib64","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1538-7836.2005.01253.x","article-title":"A\u00a0monoclonal antibody that inhibits mouse tissue factor function","volume":"3","author":"Kirchhofer","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3","key":"2023092214050475500_bib65","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1182\/blood-2012-04-424143","article-title":"Tissue factor promotes activation of coagulation and inflammation in a mouse model of sickle cell disease","volume":"120","author":"Chantrathammachart","year":"2012","journal-title":"Blood"},{"issue":"2","key":"2023092214050475500_bib66","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1172\/JCI58969","article-title":"Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin","volume":"122","author":"Owens","year":"2012","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"2023092214050475500_bib67","doi-asserted-by":"crossref","first-page":"4","DOI":"10.30802\/AALAS-JAALAS-20-000020","article-title":"Reference values for hematology, plasma biochemistry, bone marrow cytology and bone histology of NOD.Cg-Prkdc(scid) Il2rg(tm1Wjl)\/ SzJ immunodeficient mice","volume":"60","author":"Layssol-Lamour","year":"2021","journal-title":"J\u00a0Am Assoc Lab Anim Sci"},{"issue":"1","key":"2023092214050475500_bib68","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jhm.143","article-title":"Which observations from the complete blood cell count predict mortality for hospitalized patients?","volume":"2","author":"Kho","year":"2007","journal-title":"J\u00a0Hosp Med"},{"issue":"1","key":"2023092214050475500_bib69","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.beha.2014.04.005","article-title":"The coagulopathy in acute promyelocytic leukaemia--what have we learned in the past twenty years","volume":"27","author":"Kwaan","year":"2014","journal-title":"Best Pract Res Clin Haematol"},{"issue":"1","key":"2023092214050475500_bib70","first-page":"175","article-title":"Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin","volume":"2019","author":"Suzuki-Inoue","year":"2019","journal-title":"Blood"},{"issue":"9","key":"2023092214050475500_bib71","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1080\/0284186X.2022.2109424","article-title":"Shifting gears to differentiation agents in acute promyelocytic leukemia with resource constraints-a cohort study","volume":"61","author":"Vaid","year":"2022","journal-title":"Acta Oncol"},{"issue":"3","key":"2023092214050475500_bib72","first-page":"243","article-title":"FLT3-ITD allelic burden and acute promyelocytic leukemia risk stratification","volume":"10","author":"Li","year":"2021","journal-title":"Biology (Basel)"},{"key":"2023092214050475500_bib73","author":"Cingam","year":"2022"},{"issue":"suppl 1","key":"2023092214050475500_bib74","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.thromres.2017.12.018","article-title":"Mouse models of cancer-associated thrombosis","volume":"164","author":"Hisada","year":"2018","journal-title":"Thromb Res"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/18\/5458\/2080063\/blooda_adv-2023-010466-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/18\/5458\/2080063\/blooda_adv-2023-010466-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T14:06:38Z","timestamp":1695391598000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/18\/5458\/496866\/Tissue-factor-activates-the-coagulation-cascade-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":75,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2023,9,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023010466","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]}}}